NVRO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 20:09):

Stats
Dagens volum	135 234
Gjennomsnittsvolum	454 074
Markedsverdi	418.94M
EPS	$0 ( 2024-04-24 )
Neste inntjeningsdato	( $-1.020 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.50
ATR14	$0.0170 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Thornal Kevin R	Sell	24 233	Common Stock
2024-04-11	Grossman D Keith	Sell	3 986	Common Stock
2024-04-04	Rashid Kashif	Sell	479	Common Stock
2024-03-31	Kosaraju Sridhar	Buy	1 090	Common Stock
2024-03-31	Demane Michael F	Buy	1 817	Common Stock

INSIDER POWER
60.36
Last 97 transactions
Buy: 980 834 \| Sell: 269 822

Volum Korrelasjon

Lang: 0.08 (neutral)

Kort: -0.84 (strong negative)

Signal:(34.249) Neutral

Nevro Corp Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Nevro Corp Korrelasjon - Valuta/Råvare

0.02
( neutral )

0.09
( neutral )

0.00
( neutral )

0.24
( neutral )

0.79
( moderate )

-0.39
( neutral )

Nevro Corp Økonomi

Annual	2023
Omsetning:	$425.17M
Bruttogevinst:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2023
Omsetning:	$425.17M
Bruttogevinst:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2022
Omsetning:	$406.37M
Bruttogevinst:	$276.37M (68.01 %)
EPS:	$0.0850

FY	2021
Omsetning:	$386.91M
Bruttogevinst:	$266.04M (68.76 %)
EPS:	$-3.77

Financial Reports:

No articles found.

Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.